Cargando…
Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700721/ https://www.ncbi.nlm.nih.gov/pubmed/36433933 http://dx.doi.org/10.1038/s41419-022-05453-w |
| _version_ | 1784839374969503744 |
|---|---|
| author | Cheng, Xiaojing Fan, Kelong Wang, Lin Ying, Xiangji Sanders, Andrew J. Guo, Ting Xing, Xiaofang Zhou, Meng Du, Hong Hu, Ying Ding, Huirong Li, Ziyu Wen, Xianzi Jiang, Wenguo Yan, Xiyun Ji, Jiafu |
| author_facet | Cheng, Xiaojing Fan, Kelong Wang, Lin Ying, Xiangji Sanders, Andrew J. Guo, Ting Xing, Xiaofang Zhou, Meng Du, Hong Hu, Ying Ding, Huirong Li, Ziyu Wen, Xianzi Jiang, Wenguo Yan, Xiyun Ji, Jiafu |
| author_sort | Cheng, Xiaojing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9700721 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97007212022-11-27 Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer Cheng, Xiaojing Fan, Kelong Wang, Lin Ying, Xiangji Sanders, Andrew J. Guo, Ting Xing, Xiaofang Zhou, Meng Du, Hong Hu, Ying Ding, Huirong Li, Ziyu Wen, Xianzi Jiang, Wenguo Yan, Xiyun Ji, Jiafu Cell Death Dis Correction Nature Publishing Group UK 2022-11-25 /pmc/articles/PMC9700721/ /pubmed/36433933 http://dx.doi.org/10.1038/s41419-022-05453-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Cheng, Xiaojing Fan, Kelong Wang, Lin Ying, Xiangji Sanders, Andrew J. Guo, Ting Xing, Xiaofang Zhou, Meng Du, Hong Hu, Ying Ding, Huirong Li, Ziyu Wen, Xianzi Jiang, Wenguo Yan, Xiyun Ji, Jiafu Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer |
| title | Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer |
| title_full | Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer |
| title_fullStr | Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer |
| title_full_unstemmed | Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer |
| title_short | Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer |
| title_sort | correction: tfr1 binding with h-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700721/ https://www.ncbi.nlm.nih.gov/pubmed/36433933 http://dx.doi.org/10.1038/s41419-022-05453-w |
| work_keys_str_mv | AT chengxiaojing correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT fankelong correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT wanglin correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT yingxiangji correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT sandersandrewj correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT guoting correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT xingxiaofang correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT zhoumeng correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT duhong correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT huying correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT dinghuirong correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT liziyu correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT wenxianzi correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT jiangwenguo correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT yanxiyun correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer AT jijiafu correctiontfr1bindingwithhferritinnanocarrierachievesprognosticdiagnosisandenhancesthetherapeuticefficacyinclinicalgastriccancer |